HOME >> BIOLOGY >> NEWS
Blocking cell signaling can stymie viral infections, study shows

BOSTON In a finding that represents an entirely new approach to treating viral diseases such as smallpox, scientists at Dana-Farber Cancer Institute and collaborating institutions have shown that infections can be stymied by interfering with signals used by viruses to reproduce in human cells.

The results, reported in the February issue of the Journal of Clinical Investigation, point to a possible strategy for broadly treating acute viral infections that affect millions of people worldwide. If the technique leads to a drug capable of treating people infected with the smallpox virus, it could eliminate the virus' potential as a bioterror agent.

"Certain current anti-viral medications have a number of shortcomings that make them less than ideal for treating and/or preventing illnesses," says the study's senior author, Ellis Reinherz, MD, of Dana-Farber. "The existing vaccine against smallpox, for example, poses potential health risks that make it a questionable candidate for protecting the public against an outbreak of the disease. The approach we've taken is based on a new understanding of the basic mechanisms of viral reproduction and movement the actual steps that take place once a virus has invaded the body."

In the study, Reinherz and his colleagues at Dana-Farber (Hailin Yang, PhD, Mikyung Kim, PhD, and Pedro Reche, PhD), at the University of Massachusetts Medical School (Sung-Kwon Kim, PhD, and Raymond Welsh, PhD) and at the Centers for Disease Control and Prevention (Tiara Morehead and Inger Damon, MD, PhD) used a "small molecule" drug already in development for some kinds of cancer to block a key signal in the cell machinery used by smallpox and similar viruses to propel themselves from infected cells and to reproduce in new cells. In laboratory samples of monkey kidney cells, the drug prevented the smallpox virus from spreading to other cells. In lab mice infected by a virus similar to the smallpox virus, a combination of t
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
1-Feb-2005


Page: 1 2 3 4

Related biology news :

1. Blocking beta1-integrin to treat cancer
2. Blocking a premature aging syndrome with anticancer drugs
3. Blocking blood vessels provides new option for large group of advanced lung cancer patients
4. Blocking COX-1 slows tumor growth in mice
5. Blocking PLK-1 to beat bladder cancer
6. Blocking neurodegeneration by radiation and bone marrow transfer prevents inherited glaucoma in mice
7. Blocking cell suicide switch fails to stop prion damage in mouse brains
8. Endosome-mediated signaling in plants
9. Banding together: RAS signaling of circadian output
10. Scientists report new take on sexual signaling
11. Scripps research scientists identify new regulatory mechanism for critical protein signaling domain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2019)... ... December 03, 2019 , ... ... and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, ... Inc. (“Ethicann”), a Calgary-based pharmaceutical company using botanically sourced cannabinoid oils to ...
(Date:11/27/2019)... ... ... Though the forecast for the Thanksgiving holiday might look a bit grim, there’s ... roads and the skies. It’s a new personal recipe organizer app called MINE Recipes. ... design, mouth-watering pictures of food, an optional social component and an easy-to-navigate recipe manager. ...
(Date:11/22/2019)... ... November 21, 2019 , ... The inventors of ... have announced a major step forward with that therapy, known as SurVaxM. MimiVax ... company, spun off from Roswell Park in 2012, has entered into a China-exclusive ...
Breaking Biology News(10 mins):
(Date:1/8/2020)... ... January 08, 2020 , ... Anomet ... achieve specific properties for use in harsh environments inside or outside of the ... to three metals or alloys to achieve specific properties such as corrosion-resistance, biocompatibility, ...
(Date:1/7/2020)... Kingdom (PRWEB) , ... January 07, 2020 , ... ... recombinant antibody products and services, today announced the launch of its VivopureX™ recombinant ... popular antibody clones, many originally obtained from rats or hamsters, which Absolute Antibody ...
(Date:1/7/2020)... Mass. (PRWEB) , ... January 06, 2020 , ... ... for a Digital World at The Fletcher School at Tufts University, is pleased ... Sloan Foundation. The grant will be administered by Tufts University, and will help ...
(Date:1/7/2020)... ... January 06, 2020 , ... ABCT , the Accelerator ... invited to participate in the annual program. Twelve ventures will participate in the ... professional network. All startups will receive an entrepreneur coach, access to active business ...
Breaking Biology Technology:
Cached News: